BRENDA MIHALAKIS: Open Payments
NPI 1891470654 · CADES, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 36 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $191 |
| Novo Nordisk Inc | 7 | $170 |
| Verity Pharmaceuticals Inc. | 3 | $74 |
| SANOFI-AVENTIS U.S. LLC | 2 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Viatris Specialty LLC | 1 | $34 |
| TOLMAR, INC. | 2 | $31 |
| Alkermes, Inc. | 1 | $28 |
| Globus Medical, Inc. | 1 | $25 |
Products named: QULIPTA, Wegovy, Tlando, TZIELD, Ozempic, VRAYLAR, GVOKE HYPOPEN, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
